ALXO — ALX ONCOLOGY HLDGS INC COM

Ownership history in EverSource Wealth Advisors, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EverSource Wealth Advisors, LLC reported a position in ALX ONCOLOGY HLDGS INC COM (ALXO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 499 -130 -20.7% 0.00% $913 $1.83
2025 Q2 ADDED 629 +99 +18.7% 0.00% $261 $0.41
2025 Q1 INITIATED 530 — — 0.00% $330 $0.62
% of Fund (quarterly)    ALXO price (monthly, adj. close)

Other funds also holding ALXO

As of 2025 Q4 — sorted by position size

venBio Partners LLC 3Y 5.07% Almitas Capital LLC 3Y 7Y 0.63% Redmile Group, LLC 3Y 7Y 0.27% Seven Fleet Capital Management LP 0.1% HC Advisors, LLC 3Y 0.02% DRIEHAUS CAPITAL MANAGEMENT LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% JSF Financial, LLC 3Y 0.0% NAN FUNG TRINITY (HK) Ltd 3Y 0.0% Abel Hall, LLC 0.0%
← Back to EverSource Wealth Advisors, LLC Holdings